GB1372175A - 3alpha-hydroxy-pregn-4-enes - Google Patents
3alpha-hydroxy-pregn-4-enesInfo
- Publication number
- GB1372175A GB1372175A GB5303870A GB5303870A GB1372175A GB 1372175 A GB1372175 A GB 1372175A GB 5303870 A GB5303870 A GB 5303870A GB 5303870 A GB5303870 A GB 5303870A GB 1372175 A GB1372175 A GB 1372175A
- Authority
- GB
- United Kingdom
- Prior art keywords
- prepared
- hydroxy
- dione
- pregn
- hydroxypregn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- BXXMZDAZGQYNGT-OSBZKKERSA-N (3R,8S,9S,10R,13R,14S,17S)-17-ethyl-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol Chemical class O[C@H]1C=C2CC[C@H]3[C@@H]4CC[C@H](CC)[C@]4(CC[C@@H]3[C@]2(CC1)C)C BXXMZDAZGQYNGT-OSBZKKERSA-N 0.000 title 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 3
- 230000018044 dehydration Effects 0.000 abstract 3
- 238000006297 dehydration reaction Methods 0.000 abstract 3
- 230000003301 hydrolyzing effect Effects 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 229940093476 ethylene glycol Drugs 0.000 abstract 2
- 150000003431 steroids Chemical class 0.000 abstract 2
- PBPPFZWEBAAFEN-PPUJWOGTSA-N (8S,9S,10R,11R,13S,14S,17S)-11-hydroxy-10,13-dimethyl-17-(2-methyl-1,3-dioxolan-2-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one Chemical compound C1OC(C)([C@H]2CC[C@H]3[C@@H]4CCC5=CC(CC[C@]5(C)[C@H]4[C@@H](C[C@]23C)O)=O)OC1 PBPPFZWEBAAFEN-PPUJWOGTSA-N 0.000 abstract 1
- DJVDBKCOQPFYBH-BMHRSWJNSA-N (8s,9s,10r,13s,14s,17s)-10,13-dimethyl-17-(2-methyl-1,3-dioxolan-2-yl)-2,6,7,8,9,12,14,15,16,17-decahydro-1h-cyclopenta[a]phenanthrene-3,11-dione Chemical compound CC1([C@@H]2[C@]3(CC(=O)[C@@H]4[C@@]5(C)CCC(=O)C=C5CC[C@H]4[C@@H]3CC2)C)OCCO1 DJVDBKCOQPFYBH-BMHRSWJNSA-N 0.000 abstract 1
- QWVWXRKHAXWWSV-QYYVTAPASA-N 1-[(3r,8s,9s,10r,13s,14s,17s)-3-hydroxy-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl]ethanone Chemical compound C1CC2=C[C@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 QWVWXRKHAXWWSV-QYYVTAPASA-N 0.000 abstract 1
- WKAVAGKRWFGIEA-DADBAOPHSA-N 11-Ketoprogesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2=O WKAVAGKRWFGIEA-DADBAOPHSA-N 0.000 abstract 1
- WKAVAGKRWFGIEA-UHFFFAOYSA-N 11-Ketoprogesterone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(=O)C)C1(C)CC2=O WKAVAGKRWFGIEA-UHFFFAOYSA-N 0.000 abstract 1
- BFZHCUBIASXHPK-QJSKAATBSA-N 11alpha-hydroxyprogesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)C[C@H]2O BFZHCUBIASXHPK-QJSKAATBSA-N 0.000 abstract 1
- 239000008351 acetate buffer Substances 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- FBCCMZVIWNDFMO-UHFFFAOYSA-N dichloroacetyl chloride Chemical compound ClC(Cl)C(Cl)=O FBCCMZVIWNDFMO-UHFFFAOYSA-N 0.000 abstract 1
- UVYVLBIGDKGWPX-KUAJCENISA-N digitonin Chemical class O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O[C@H]5[C@@H]([C@@H](O)[C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)CO7)O)[C@H](O)[C@@H](CO)O6)O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)[C@@H](CO)O6)O)[C@@H](CO)O5)O)C[C@@H]4CC[C@H]3[C@@H]2[C@@H]1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVYVLBIGDKGWPX-KUAJCENISA-N 0.000 abstract 1
- 238000006073 displacement reaction Methods 0.000 abstract 1
- 230000032050 esterification Effects 0.000 abstract 1
- 238000005886 esterification reaction Methods 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000269 nucleophilic effect Effects 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Abstract
1372175 3α-Hydroxy-pregn-4-enes and their esters GLAXO LABORATORIES Ltd 5 Nov 1971 [6 Nov 1970] 53038/70 Heading C2U [Also in Division A5] Novel pregn-4-enes and 19-nor-pregn-4-enes, excluding 3α-hydroxypregn-4-en-20-one, possess a 3α-(free or esterified hydroxy group) group, a 17#-acetyl group together with a 17α-hydrogen atom, and in the 11-position two hydrogen atoms or an oxo group. The esterified hydroxy group is derived from an optionally carboxy- or halosubstituted C 1-5 alkanoic acid. The steroids may contain further substituents in undefined positions, particularly in the 2- and 16- positions, e.g. 16-CH 3 and 2#-(alkyl, alkoxy and halo). They may be prepared, for example, (a) by nucleophilic displacement of an allylically replaceable 3#-substituent in a suitable steroid containing a 2#-hydrogen atom by the required 3α-(free or esterified hydroxy group); or (b) for a product containing a 2#-substituent, by reacting an appropriate 2α,3α-epoxy-5α-ol with R<SP>2</SP>H (R<SP>2</SP> is C 1-5 alkyl, C 1-6 alkoxy or halogen) or a compound furnishing an anion R<SP>2-</SP> and a cation to give the corresponding 2#-R<SP>2</SP>-3α-ol (or a metal salt thereof) followed by treatment with a proton source when necessary and then dehydration to form the #<SP>4</SP>-double bond, the 3α-OH group being protected during dehydration and subsequently released. Resulting 3α-ols may subsequently be esterified. In one example 3#-dichloroacetoxypregn-4-en- 20-one (prepared from the free 3#-ol and dichloroacetyl chloride) is refluxed with an acetate buffer solution to give, in addition to the required 3α-ol, some 3#-hydrozy-pregn-4-en-20-one and 5α - hydroxy - pregn - 3 - en - 20 - one; the last-mentioned is separated from the 3α-ol by preparative T.L.C. and the 3#- and 3α-ols, and other similarly formed 3α- and 3#-ol mixtures, are separated via the digitonin complexes of the 3#-ols. In another example dehydration of 3α- acetoxy - 5α - hydroxy - 2# - methoxypregnan- 20-one gives not only the required #<SP>4</SP>-compound but also 3α-acetoxy-2#-methoxypregn-5-en-20- one. 3# - Hydroxypregn - 4 - ene - 11,20 - dione is prepared by converting 3-[pyrrolidin-1-yl)- pregna -3,5 - dien - 11,20 - dione (prepared from 11-oxo-progesterone and pyrrolidine) to the enaminium chloride, reacting this with ethyleneglycol and hydrolysing to give 20,20-ethylenedioxypregn - 4 - ene - 3,11 - dione, reducing this to 20,20-ethylenedioxy-3#-hydroxypregn-4- en-11-one and'hydrolysing this; the intermediate 3,11-dione may alternatively be prepared by oxidation of 20, 20-ethylenedioxy-11α-hydroxypregn-4-en-3-one, in turn prepared by converting 11α - hydroxypregn - 4 - ene - 3,20 - dione to 11α - hydroxy - 3 - (pyrrolidin - 1 - yl) - pregna- 3,5-dien-20-one, converting this to the enaminiurn chloride and reacting this with ethylene glycol and hydrolysing to the 3-one. 3#-Dichloroacetoxypregn - 4 - ene - 11,20 - dione and 3α - acetoxy - 5α - hydroxy - 2# - methoxypregnan- 20-one are prepared by esterification of the corresponding 3-ols, 3α,5α-dihdroxy-2#-methoxypregn-20-one being in turn prepared from 2α,3α- epoxy-5α-hydroxypregnan-20-one and methanol.
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5303870A GB1372175A (en) | 1970-11-06 | 1970-11-06 | 3alpha-hydroxy-pregn-4-enes |
BE774988A BE774988A (en) | 1970-11-06 | 1971-11-05 | PREGNANE SERIES COMPOUNDS WITH ANESTHESIC ACTIVITY AND THEIR PREPARATION |
AU35398/71A AU470121B2 (en) | 1970-11-06 | 1971-11-05 | 3&-hydroxy-pregn-4-enes |
DE19712155137 DE2155137A1 (en) | 1970-11-06 | 1971-11-05 | Pregnan range steroids |
CA126,960A CA981251A (en) | 1970-11-06 | 1971-11-05 | Compounds of the pregnane series having useful anaesthetic activity |
DK542071AA DK128898B (en) | 1970-11-06 | 1971-11-05 | Analogous process for the preparation of 3α-oxygenated pregn-4-en-20-ones. |
FR7139810A FR2112503B1 (en) | 1970-11-06 | 1971-11-05 | |
ZA717449A ZA717449B (en) | 1970-11-06 | 1971-11-05 | Compounds of the pregnane series having useful anaesthetic activity |
NL7115297A NL7115297A (en) | 1970-11-06 | 1971-11-05 | |
IL38112A IL38112A (en) | 1970-11-06 | 1971-11-09 | 3alpha-hydroxy-pregn-4-en-20-one and esters thereof their preparation and anesthetic com positions comprising them |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5303870A GB1372175A (en) | 1970-11-06 | 1970-11-06 | 3alpha-hydroxy-pregn-4-enes |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1372175A true GB1372175A (en) | 1974-10-30 |
Family
ID=10466377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB5303870A Expired GB1372175A (en) | 1970-11-06 | 1970-11-06 | 3alpha-hydroxy-pregn-4-enes |
Country Status (10)
Country | Link |
---|---|
AU (1) | AU470121B2 (en) |
BE (1) | BE774988A (en) |
CA (1) | CA981251A (en) |
DE (1) | DE2155137A1 (en) |
DK (1) | DK128898B (en) |
FR (1) | FR2112503B1 (en) |
GB (1) | GB1372175A (en) |
IL (1) | IL38112A (en) |
NL (1) | NL7115297A (en) |
ZA (1) | ZA717449B (en) |
-
1970
- 1970-11-06 GB GB5303870A patent/GB1372175A/en not_active Expired
-
1971
- 1971-11-05 CA CA126,960A patent/CA981251A/en not_active Expired
- 1971-11-05 FR FR7139810A patent/FR2112503B1/fr not_active Expired
- 1971-11-05 ZA ZA717449A patent/ZA717449B/en unknown
- 1971-11-05 DK DK542071AA patent/DK128898B/en unknown
- 1971-11-05 AU AU35398/71A patent/AU470121B2/en not_active Expired
- 1971-11-05 DE DE19712155137 patent/DE2155137A1/en active Pending
- 1971-11-05 NL NL7115297A patent/NL7115297A/xx not_active Application Discontinuation
- 1971-11-05 BE BE774988A patent/BE774988A/en unknown
- 1971-11-09 IL IL38112A patent/IL38112A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA981251A (en) | 1976-01-06 |
AU3539871A (en) | 1973-05-10 |
DE2155137A1 (en) | 1972-05-10 |
DK128898B (en) | 1974-07-22 |
ZA717449B (en) | 1973-06-27 |
AU470121B2 (en) | 1976-03-04 |
FR2112503A1 (en) | 1972-06-16 |
IL38112A (en) | 1977-06-30 |
FR2112503B1 (en) | 1975-11-28 |
NL7115297A (en) | 1972-05-09 |
IL38112A0 (en) | 1972-03-28 |
BE774988A (en) | 1972-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1475795A (en) | Steroid 21-thioesters | |
IL72702A0 (en) | Steroidal carboxylic acid esters,their manufacture and pharmaceutical compositions containing them | |
GB1478357A (en) | Haptene derivatives of estrogens processes for preparing them and methods of preparing antigens from them | |
GB1372175A (en) | 3alpha-hydroxy-pregn-4-enes | |
GB1037162A (en) | Improvements in or relating to 19-oxo-androstane compounds and derivatives thereof | |
GB1147801A (en) | Improvements in or relating to novel steroids and the manufacture thereof | |
US2837517A (en) | 9, 11beta-epoxy-17-alkyltestosterones | |
GB1277266A (en) | 07-acetylgonanes and derivatives therefor | |
GB1352027A (en) | Process for the manufacture of pregnane compounds and process for the manufacture of sulphite esters | |
GB1099008A (en) | Novel unsaturated steroids, and processes for their preparation | |
GB1365205A (en) | Process for the manufacture of 17-/2-haloalkylidene/-steroids | |
GB1514621A (en) | 13-ethynyl-and 13-(2-halovinyl)-steroids and their preparation | |
ES400163A1 (en) | Novel pregnanoic acid derivatives | |
GB1303008A (en) | ||
GB921534A (en) | Cyclopentanophenanthrene derivatives and process for the production thereof | |
GB1130189A (en) | Improvements in or relating to steroid intermediates and the production thereof | |
GB973328A (en) | Steroid compounds | |
GB980245A (en) | New-6-alkyl-steroids | |
GB976818A (en) | 4-alkanoylthio- and 4-aroylthio-3-keto-í¸-steroids and process for the preparation thereof | |
GB1101791A (en) | New 1ª‡:7ª‡-dimethyl steroids and a process for their manufacture | |
GB1255186A (en) | New 22,25-epoxy-steroids and a process for their manufacture | |
GB1003305A (en) | Novel steroid compounds and their preparation | |
GB973899A (en) | Novel steroid compounds and their preparation | |
GB1053214A (en) | ||
GB1061036A (en) | Steroidal 6-chloro-4,6-dienes and preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
429A | Application made for amendment of specification (sect. 29/1949) | ||
429H | Application (made) for amendment of specification now open to opposition (sect. 29/1949) | ||
429D | Case decided by the comptroller ** specification amended (sect. 29/1949) | ||
PCNP | Patent ceased through non-payment of renewal fee |